GlassScriptPhysician profile
Kathryn C Bachman
NPI 1942857859
$8,064.99
in general payments reported to CMS, 2019-2025
40 companies · $970 in 2025
The $970 reported for 2025 was more than what 80% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,407 · 2022: $982 · 2023: $3,283 · 2024: $1,423 · 2025: $970.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,499 · Travel and Lodging: $1,177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,499.32 |
| Travel and Lodging | $1,176.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,785.51 | 2022-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Scilex Pharmaceuticals INC. | $903.91 | 2021-2025 | Ztlido |
| Si-Bone, INC. | $837.50 | 2021 | |
| Collegium Pharmaceutical, INC. | $588.05 | 2022-2025 | Xtampza, Belbuca |
| Amgen INC. | $583.76 | 2021-2025 | Evenity, Prolia, Prolia |
| Nevro Corp. | $571.52 | 2023-2024 | Senza, Vyrsa V1 |
| Abbvie INC. | $561.04 | 2021-2025 | |
| Vertos Medical, INC. | $381.83 | 2021-2024 | Mild Device Kit |
| Averitas Pharma INC. | $240.34 | 2023-2025 | Qutenza |
| Tersera Therapeutics LLC | $172.96 | 2021-2025 | Prialt |
| Saluda Medical Americas, INC. | $150.78 | 2025 | Evoke |
| Mml US, INC. | $133.77 | 2024 | Reactiv8 |
| Ipsen Biopharmaceuticals, INC | $109.24 | 2022-2024 | Dysport |
| Almatica Pharma LLC | $107.52 | 2021-2023 | Gralise |
| Ferring Pharmaceuticals INC. | $104.90 | 2024-2025 | Euflexxa |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Bachman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.